BioSpace News Archive

This year marks the 4th anniversary of the Public Health Excellence in Interprofessional Education Collaboration Award, which was established to acknowledge and celebrate outstanding multidisciplinary efforts to impact community health. The U.S. Public Health Service (USPHS) and the Interprofessional Education Collaborative (IPEC) are delighted to congratulate the 2020 USPHS IPEC Award winners and four honorable mention finalists.

Waters Corporation (NYSE:WAT) will webcast its Q1 2020 financial results conference call live on Tuesday, April 28th at 8:00 a.m. eastern time. To listen to the conference call, connect to Waters’ website, www.waters.com choose “Investors” and click on the Live Webcast.

In an effort to support the global need for medical ventilators, Minnesota-based Tolomatic has dedicated a team of engineers to the development of highly efficient emergency ventilator concept systems using electric linear actuators. The proposed technologies are the first step in creating innovative emergency ventilators for patients around the world.

B. Braun Medical Inc. (B. Braun) today announced that the US Food and Drug Administration (FDA) issued Emergency Use Authorization (EUA) of B. Braun’s Perfusor® Space Syringe Infusion Pump, Infusomat® Space Volumetric Infusion Pump, and Outlook® ES Pump systems

Brooks Automation, Inc. reported preliminary financial results for the second fiscal quarter of 2020, ended March 31, 2020.

After carrying out thorough research on arbovirus testing, Persistence Market Research has come up with interesting insights on the global market and has a published a new research report titled “Arbovirus Testing Market: Global Industry Analysis (2012-2016) and Forecast (2017-2025)”.

Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) (“Amphastar” or the “Company”), a California-based, specialty, generic pharmaceutical company, today announces a recent simplification of the Company’s management by removing a layer of management in the organizational structure.

Over the years, there has been a rise in the demand for convenient and efficient drug delivery systems for patients that rely on prescription drugs on a regular basis. This creates a lucrative opportunity for pharmaceutical manufacturers all over the world to develop sophisticated, easy-to-use, and effective injectable drug delivery devices.

The new study report by Persistence Market Research (PMR) reveals that the oncolytic virus immunotherapy market value is all set to reach US$ ~67 Mn, by 2019-end. As per the PMR’s report, the oncolytic virus immunotherapy market is estimated to grow at a CAGR of ~12% over the period of assessment, 2019-2029.

In the ongoing battle against the COVID-19 pandemic, the Department of Defense seeks information from the industrial base on their capability to replenish critical medical supplies.